Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Hood

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2002
A human aminoacyl-tRNA synthetase as a regulator of angiogenesisKeisuke Wakasugi, Bonnie M Slike, John Hood, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Decoding Multicellular Communication Motifs from Spatial Transcriptomics with ALARMISTJiayi Fan, John Hood, James Strong, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2006
Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injuryJohn Doukas, Wolfgang Wrasidlo, Glenn Noronha, et al.
Human Pathology|September 5, 2006
Immunohistochemical evidence of Clostridium sp, Staphylococcus aureus, and group A Streptococcus in severe soft tissue infections related to injection drug useJeannette Guarner, Jeanine Bartlett, Sarah Reagan, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2002
A fragment of human TrpRS as a potent antagonist of ocular angiogenesisAtsushi Otani, Bonnie M Slike, Michael I Dorrell, et al.
Journal of Medicinal Chemistry|August 10, 2007
Discovery of 3,3'-(2,4-diaminopteridine-6,7-diyl)diphenol as an isozyme-selective inhibitor of PI3K for the treatment of ischemia reperfusion injury associated with myocardial infarctionMoorthy S S Palanki, Elena Dneprovskaia, John Doukas, et al.
The Journal of Clinical Investigation|May 17, 2008
Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbitsLea Scheppke, Edith Aguilar, Ray F Gariano, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|October 26, 2020
SM04755, a small-molecule inhibitor of the Wnt pathway, as a potential topical treatment for tendinopathyVishal Deshmukh, Tim Seo, Alyssa L O'Green, et al.
Cancer Research Communications|May 12, 2025
First-in-Human Study to Evaluate the Safety and Efficacy of Anti-GDF15 Antibody AZD8853 in Patients with Advanced/Metastatic Solid TumorsBenedito A Carneiro, Olumide B Gbolahan, Albiruni Abdul Abdul Razak, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 21, 2007
Metabolism and pharmacokinetics of a novel Src kinase inhibitor TG100435 ([7-(2,6-dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine) and its active N-oxide metabolite TG100855 ([7-(2,6-dichloro-phenyl)-5-methylbenzo[1,2,4]triazin-3-yl]-{4-[2-(1-oxy-pyrrolidin-1-yl)-ethoxy]-phenyl}-amine)Steven X Hu, Richard Soll, Shiyin Yee, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2002
A human aminoacyl-tRNA synthetase as a regulator of angiogenesisKeisuke Wakasugi, Bonnie M Slike, John Hood, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Decoding Multicellular Communication Motifs from Spatial Transcriptomics with ALARMISTJiayi Fan, John Hood, James Strong, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2006
Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injuryJohn Doukas, Wolfgang Wrasidlo, Glenn Noronha, et al.
Human Pathology|September 5, 2006
Immunohistochemical evidence of Clostridium sp, Staphylococcus aureus, and group A Streptococcus in severe soft tissue infections related to injection drug useJeannette Guarner, Jeanine Bartlett, Sarah Reagan, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2002
A fragment of human TrpRS as a potent antagonist of ocular angiogenesisAtsushi Otani, Bonnie M Slike, Michael I Dorrell, et al.
Journal of Medicinal Chemistry|August 10, 2007
Discovery of 3,3'-(2,4-diaminopteridine-6,7-diyl)diphenol as an isozyme-selective inhibitor of PI3K for the treatment of ischemia reperfusion injury associated with myocardial infarctionMoorthy S S Palanki, Elena Dneprovskaia, John Doukas, et al.
The Journal of Clinical Investigation|May 17, 2008
Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbitsLea Scheppke, Edith Aguilar, Ray F Gariano, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|October 26, 2020
SM04755, a small-molecule inhibitor of the Wnt pathway, as a potential topical treatment for tendinopathyVishal Deshmukh, Tim Seo, Alyssa L O'Green, et al.
Cancer Research Communications|May 12, 2025
First-in-Human Study to Evaluate the Safety and Efficacy of Anti-GDF15 Antibody AZD8853 in Patients with Advanced/Metastatic Solid TumorsBenedito A Carneiro, Olumide B Gbolahan, Albiruni Abdul Abdul Razak, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 21, 2007
Metabolism and pharmacokinetics of a novel Src kinase inhibitor TG100435 ([7-(2,6-dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine) and its active N-oxide metabolite TG100855 ([7-(2,6-dichloro-phenyl)-5-methylbenzo[1,2,4]triazin-3-yl]-{4-[2-(1-oxy-pyrrolidin-1-yl)-ethoxy]-phenyl}-amine)Steven X Hu, Richard Soll, Shiyin Yee, et al.
Pageof 5